Introduction and Objectives
• Equine recurrent uveitis (ERU), also called "moon blindness", iridocyclitis, or periodic ophthalmia is the most common cause of blindness in horses [1] . Several organisms have been associated with ERU, with leptospires being the most commonly reported agent [2] . In general, the prognosis for eyes affected by ERU is poor, as most horses have recurrent episodes that eventually lead to vision deficits. Ocular involvements (unilateral or bilateral visual impairment or blindness) increase, irrespective of substantial treatment costs, hence reducing the value of affected horses progressively [3] . • This study aimed (a) to quantify the number of horses currently affected by ERU in the U.S., thereby differentiating between ERU associated with leptospiral infection and other reasons, (b) to quantify the visual impairments with ERU, accounting for breed differences, and (c) to estimate the associated loss of value in horses currently affected by ERU in the U.S. 
Conclusions
• Approximately 576,000 horses are currently affected by ERU in the U.S., from which more than 300,000 horses are or are expected to become blind in one or both eyes.
• Considering horses with ERU associated with leptospiral infection only, more than 400,000 horses are affected, with 210,000 being or becoming blind in one or both eyes.
• ERU represents a substantial economic burden which conservatively calculates to more than $ 800 MM due to the loss of horse value, not considering treatment costs. 70% of these losses (i.e. more than $ 560 MM) can be attributed to leptospiral ERU. 
Results
• Considering 7.2 MM horses and an overall risk of ERU of 8%, the number of horses currently affected by ERU in the U.S. was calculated to 576,000. Accounting for breed differences in risk, Appaloosas were overrepresented and Thoroughbreds and Standardbreds were underrepresented when comparing with the overall U.S. horse population.
• 70% of all ERU cases have been reported to be associated with leptospires, totaling to more than 400,000 horses in the U.S.
• From all horses affected, 198,513 and 104,269 already are or are expected to become blind in one or both eyes during the next 11 years, respectively. From those horses being impaired but maintaining vision, 151,046 horses are unilaterally and 122,172 bilaterally affected.
• Considering the average value of horses as well as the loss of value with different ocular involvements, depreciations were calculated to approximately $ 800 MM over all U.S. horses currently affected by ERU. It was estimated that 70% of those losses are associated with leptospires, totaling to more than $ 560 MM, not accounting for costs of diagnosis or treatment. 
